Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

✍ Scribed by Andre, T.; Blons, H.; Mabro, M.; Chibaudel, B.; Bachet, J.-B.; Tournigand, C.; Bennamoun, M.; Artru, P.; Nguyen, S.; Ebenezer, C.; Aissat, N.; Cayre, A.; Penault-Llorca, F.; Laurent-Puig, P.; de Gramont, A.

• Book ID: 118141849
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 275 KB
• Volume: 24
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mds465